Evidence map›Paper›PMID 28805809›Full record

ArticleNature structural & molecular biology2017

X-ray structures of endothelin ET

Wataru Shihoya, Tomohiro Nishizawa, Keitaro Yamashita, Asuka Inoue, Kunio Hirata, Francois Marie Ngako Kadji, Akiko Okuta, Kazutoshi Tani, Junken Aoki, Yoshinori Fujiyoshi and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature structural & molecular biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 102 citations in OpenAlex.

  1. Review
  2. Review
  3. Structure of a lasso peptide bound ETNature communications · 2025
    Article
  4. Structure of endothelin ETCommunications biology · 2024
    Article
  5. Article
  6. G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.International journal of molecular sciences · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Structures of human gastrin-releasing peptide receptors bound to antagonist and agonist for cancer and itch therapy.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Wataru ShihoyaDepartment of Basic Medicinal Sciences, Graduate School of Pharmaceutical Sciences, Nagoya University, Nagoya, Japan.
Tomohiro NishizawaDepartment of Biophysics and Biochemistry, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
Keitaro YamashitaRIKEN SPring-8 Center, Sayo, Japan.ORCID http://orcid.org/0000-0002-5442-7582
Asuka InouePrecursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency, Kawaguchi, Japan.
Kunio HirataPrecursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency, Kawaguchi, Japan.
Francois Marie Ngako KadjiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Akiko OkutaCellular and Structural Physiology Institute, Nagoya University, Nagoya, Japan.
Kazutoshi TaniCellular and Structural Physiology Institute, Nagoya University, Nagoya, Japan.ORCID http://orcid.org/0000-0003-4835-154X
Junken AokiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Yoshinori FujiyoshiDepartment of Basic Medicinal Sciences, Graduate School of Pharmaceutical Sciences, Nagoya University, Nagoya, Japan.
Tomoko DoiDepartment of Biophysics, Graduate School of Science, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-6568-4576
Osamu NurekiDepartment of Biophysics and Biochemistry, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
Nagoya University · JPTohoku University · JPJapan Science and Technology Agency · JPKyoto University · JPSPring-8 · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelin receptors (ETRs) have crucial roles in vascular control and are targets for drugs designed to treat circulatory-system diseases and cancer progression. The nonpeptide dual-ETR antagonist bosentan is the first oral drug approved to treat pulmonary arterial hypertension. Here we report crystal structures of human endothelin ET

Indexed as

BosentanCrystallography, X-RayEndothelin Receptor AntagonistsHumansModels, MolecularProtein BindingProtein ConformationReceptor, Endothelin BSulfonamidesBosentanEDNRB protein, humanEndothelin Receptor AntagonistsReceptor, Endothelin BSulfonamides

Identifiers

PMID28805809
OpenAlexW2748712988

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.